Laurus Labs Limited Net Assets

Latest as of March 2026: Rs54.31 Billion INR ≈ $587.38 Million USD

Laurus Labs Limited net assets. Based on the latest financial reports, Laurus Labs Limited (LAURUSLABS) has net assets worth Rs54.31 Billion INR (≈ $587.38 Million USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rs105.11 Billion ≈ $1.14 Billion USD) and total liabilities (Rs50.80 Billion ≈ $549.36 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore LAURUSLABS year-over-year net asset growth to track the company's year-over-year net asset growth rate.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Rs54.31 Billion
% of Total Assets	51.67%
Annual Growth Rate	26.37%
5-Year Change	61.69%
10-Year Change	308.24%
Growth Volatility	26.04

Net Assets of Laurus Labs Limited (2013–2026)

Net assets of Laurus Labs Limited from 2013 to 2026. This chart illustrates how Laurus Labs Limited's net assets have evolved over time, based on quarterly financial data. See LAURUSLABS net asset quality index to measure how much of total assets are equity-financed.

Annual Net Assets for Laurus Labs Limited (2013–2026)

The table below shows the annual net assets of Laurus Labs Limited from 2013 to 2026. For live market cap and overall valuation, see how much is Laurus Labs Limited worth.

Year	Net Assets	Change
2026-03-31	Rs54.31 Billion ≈ $587.38 Million	+18.01%
2025-03-31	Rs46.03 Billion ≈ $497.75 Million	+11.83%
2024-03-31	Rs41.16 Billion ≈ $445.08 Million	+1.65%
2023-03-31	Rs40.49 Billion ≈ $437.85 Million	+20.53%
2022-03-31	Rs33.59 Billion ≈ $363.27 Million	+29.16%
2021-03-31	Rs26.01 Billion ≈ $281.26 Million	+46.95%
2020-03-31	Rs17.70 Billion ≈ $191.39 Million	+13.56%
2019-03-31	Rs15.58 Billion ≈ $168.54 Million	+5.11%
2018-03-31	Rs14.83 Billion ≈ $160.34 Million	+11.44%
2017-03-31	Rs13.30 Billion ≈ $143.88 Million	+56.19%
2016-03-31	Rs8.52 Billion ≈ $92.12 Million	+18.17%
2015-03-31	Rs7.21 Billion ≈ $77.96 Million	+101.12%
2014-03-31	Rs3.58 Billion ≈ $38.76 Million	+38.23%
2013-03-31	Rs2.59 Billion ≈ $28.04 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Laurus Labs Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have grown by 6702.4% over the analyzed period, indicating profitable operations and earnings retention.

Laurus Labs Limited Net Assets Breakdown (March 2026)

Laurus Labs Limited net assets breakdown by equity component as of March 2026.

Component	Amount	Percentage
Retained Earnings	Rs44.29 Billion	83.56%
Common Stock	Rs1.08 Billion	2.04%
Other Comprehensive Income	Rs-15.90 Million	-0.03%
Other Components	Rs7.65 Billion	14.43%
Total Equity	Rs53.00 Billion	100.00%

Laurus Labs Limited Competitors by Market Cap

The table below lists competitors of Laurus Labs Limited ranked by their market capitalization.

Company	Market Cap
Huazhu Group Ltd NASDAQ:HTHT	$13.59 Billion
B3 S.A. - Brasil Bolsa Balcão SA:B3SA3	$13.59 Billion
Kinsus Interconnect Technology Corp TW:3189	$13.60 Billion
BE SEMICON.INDS NY EO091 F:BSIA	$13.60 Billion
KT&G Corp KO:033780	$13.56 Billion
Rede D'Or São Luiz S.A. SA:RDOR3	$13.55 Billion
Scentre Group AU:SCG	$13.53 Billion
Norsk Hydro ASA OL:NHY	$13.51 Billion

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Laurus Labs Limited's equity between the two most recent reporting periods.

Equity Growth Insights

From 2025 to 2026, total equity changed from 44,725,600,000 to 53,000,600,000, a change of 8,275,000,000 (18.5%).
Net income of 8,887,900,000 contributed positively to equity growth.
Dividend payments of 863,300,000 reduced retained earnings.
New share issuances of 200,000,000 increased equity.
Other comprehensive income decreased equity by 69,700,000.

Equity Change Factors (2025 to 2026)

Factor	Impact	Contribution
Net Income	Rs8.89 Billion	+16.77%
Dividends Paid	Rs863.30 Million	-1.63%
Share Issuances	Rs200.00 Million	+0.38%
Other Comprehensive Income	Rs-69.70 Million	-0.13%
Other Changes	Rs120.10 Million	+0.23%
Total Change	Rs-	18.50%

Book Value vs Market Value Analysis

This analysis compares Laurus Labs Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 23.68x
The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
The price-to-book ratio has decreased from 364.10x to 23.68x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2013-03-31	Rs6.38	Rs2323.00	x
2014-03-31	Rs8.08	Rs2323.00	x
2015-03-31	Rs16.25	Rs2323.00	x
2016-03-31	Rs17.31	Rs2323.00	x
2017-03-31	Rs29.23	Rs2323.00	x
2018-03-31	Rs27.88	Rs2323.00	x
2019-03-31	Rs29.26	Rs2323.00	x
2020-03-31	Rs33.18	Rs2323.00	x
2021-03-31	Rs48.27	Rs2323.00	x
2022-03-31	Rs62.15	Rs2323.00	x
2023-03-31	Rs74.82	Rs2323.00	x
2024-03-31	Rs76.18	Rs2323.00	x
2025-03-31	Rs82.89	Rs2323.00	x
2026-03-31	Rs98.10	Rs2323.00	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Laurus Labs Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 16.77%
The company demonstrates strong efficiency in generating profits from shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 13.05%
• Asset Turnover: 0.65x
• Equity Multiplier: 1.98x
Recent ROE (16.77%) is below the historical average (16.80%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2013	34.02%	12.28%	1.02x	2.71x	Rs622.88 Million
2014	19.08%	5.15%	1.04x	3.55x	Rs325.27 Million
2015	9.48%	5.15%	0.72x	2.56x	Rs-37.17 Million
2016	15.70%	7.52%	0.77x	2.70x	Rs485.53 Million
2017	14.30%	9.99%	0.72x	1.99x	Rs572.31 Million
2018	11.30%	8.15%	0.68x	2.03x	Rs193.46 Million
2019	6.02%	4.09%	0.69x	2.14x	Rs-620.77 Million
2020	14.42%	9.01%	0.76x	2.12x	Rs782.92 Million
2021	37.87%	20.43%	0.84x	2.21x	Rs7.24 Billion
2022	24.69%	16.77%	0.71x	2.08x	Rs4.92 Billion
2023	19.57%	13.08%	0.79x	1.90x	Rs3.86 Billion
2024	3.91%	3.18%	0.60x	2.04x	Rs-2.51 Billion
2025	8.01%	6.45%	0.59x	2.09x	Rs-889.36 Million
2026	16.77%	13.05%	0.65x	1.98x	Rs3.59 Billion

Industry Comparison

This section compares Laurus Labs Limited's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.

Industry Context

Industry: Drug Manufacturers - Specialty & Generic
Average net assets among peers: $18,296,965,823
Average return on equity (ROE) among peers: 13.70%

Peer Company Comparison

Company	Net Assets	Return on Equity	Debt-to-Equity	Market Cap
Laurus Labs Limited (LAURUSLABS)	Rs54.31 Billion	34.02%	0.94x	$13.57 Billion
Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS)	$1.38 Billion	2.91%	0.72x	$32.43 Million
Aarti Drugs Limited (AARTIDRUGS)	$13.69 Billion	12.28%	0.88x	$460.26 Million
Aarti Pharmalabs Limited (AARTIPHARM)	$15.58 Billion	12.42%	0.44x	$901.84 Million
Abbott India Limited (ABBOTINDIA)	$20.09 Billion	22.42%	0.46x	$5.93 Billion
Ajanta Pharma Limited (AJANTPHARM)	$37.90 Billion	24.28%	0.32x	$4.49 Billion
Akums Drugs and Pharmaceutical (AKUMS)	$30.64 Billion	11.04%	0.34x	$1.26 Billion
Alkem Laboratories Limited (ALKEM)	$12.05 Billion	19.50%	0.29x	$6.77 Billion
Amrutanjan Health Care Limited (AMRUTANJAN)	$949.51 Million	15.88%	0.30x	$155.76 Million
Alembic Pharmaceuticals Limited (APLLTD)	$27.18 Billion	21.50%	0.76x	$1.71 Billion
Aurobindo Pharma Limited (AUROPHARMA)	$23.50 Billion	-5.26%	1.65x	$10.54 Billion

About Laurus Labs Limited

NSE:LAURUSLABS India Drug Manufacturers - Specialty & Generic

Market Cap

$13.57 Billion

Rs1.26 Trillion INR

Market Cap Rank

#1722 Global

#59 in India

Share Price

Rs2323.00

Change (1 day)

-1.06%

52-Week Range

Rs944.90 - Rs2405.50

All Time High

Rs2405.50